Search Results for Tag : cipla
Notifications & Circulars
Central Government permitted M/s. Cipla Limited to import morphine, codeine, the baine and their salts after following the procedure specified in NDPS Rules(27.08.2020)
1. In exercise of the powers conferred by the proviso to rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985, the Central Government.....
Tags : Cipla Limited, Permission, Import
Judgments
High Court finds in favour of Hoffmann-La Roche(27.11.2015)
The Delhi High Court allowed La Roche’s appeal for grant of injunction against Cipla with regard to infringement of patent, ‘IN ’774’, which was claim.....
Tags : Patent, la roche, cipla, inventiveness, obviousness
News
CCI Nods for Investment by FIL Capital(22.01.2016)
Competition Commission of India (CCI) has granted approval to proposed investment by FIL Capital Investments (Mauritius) II Limited in Cipla Health Li.....
Tags : Competition Commission of India, FIL Capital Investments, Cipla Health Limited
Delhi High Court Bars Cipla From Selling Novartis Respiratory Drug ‘Onbrez’ in India(10.03.2017)
Delhi High Court has barred Cipla Ltd from selling copies of Novartis AG’s respiratory drug Onbrez in India, upholding patents held by swiss drug make.....
Tags : Delhi High Court, Cipla, Novartis Respiratory Drug
SC Directs Cipla to Deposit Rs 175.07 Crore(25.07.2016)
SC has asked drug maker, Cipla Ltd. to deposit Rs 175.07 crore with regard to cases pertaining to overcharging of certain drugs.
Tags : SC , Cipla
SC Disposes off Cipla’s Appeal Against Roche as Withdrawn(19.06.2017)
Supreme Court has allowed withdrawal of Special Leave Petitions against Delhi High Court’s 2015 judgment holding that Cipla had infringed Roche’s pate.....
Tags : Supreme Court, Cipla, Roche
SC Admits Cipla’s Plea against La Roche(28.01.2016)
SC has admitted plea of generic drug manufacturer Cipla Ltd challenging Delhi HC order holding it guilty of infringing Swiss pharma company Hoffmann-L.....
Tags : SC , Cipla, Hoffmann-La Roche
Cipla Gets CCI’s Approval to Sell 26% in Consumer Healthcare Business(29.01.2016)
Cipla Health Ltd has received approval from Competition Commission of India (CCI) to sell about 26 per cent stake in its consumer healthcare business.....
Tags : Cipla Health Ltd , Competition Commission of India